Silence Therapeutics Plc (SLNCF)
1.06
-0.39
(-27.02%)
USD |
OTCM |
May 20, 15:59
Silence Therapeutics EPS Diluted (Quarterly) : -0.1055 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.96M |
| Revenue (Quarterly) | 0.422M |
| Total Expenses (Quarterly) | 15.38M |
| Enterprise Value | 135.88M |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -3.54K% |
| Earnings Yield | -49.95% |
| Normalized Earnings Yield | -49.34 |